EUVIMEDEUVIMED entdecken
Open Access

Increased methylation levels of the MTHFR gene promoter in Down syndrome

Dijana Majstorović iD, Andrea Stoccoro iD, Anita Barišić iD, Alena Buretić Tomljanović iD, Marianna Giangreco, Vanessa Nicolì iD, Fabio Coppedè iD, Jadranka Vraneković iD

Epigenomics · 2025

DOI: 10.1080/17501911.2025.2563501 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epigenomics, 2025. Verfasst von Dijana Majstorović und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Juraj Dobrila University of Pula, Pula, Croatia. Hauptthemen laut MEDLINE: Methylenetetrahydrofolate Reductase (NADPH2), Down Syndrome, DNA Methylation, Promoter Regions, Genetic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: University of Rijeka, Rijeka, Croatia under Grant, Juraj Dobrila University of Pula, Croatia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: MTHFR is a key enzyme in the one-carbon metabolic pathway, whose activity has been implicated in Down syndrome (DS) and in the development of congenital heart defects (CHDs). The main aim was to assess promoter methylation levels of the MTHFR gene in DS individuals, including those with congenital heart defects (DS-CHD+), and those without (DS-CHD-), as well as control subjects. We also investigated if common MTHFR polymorphisms, namely 677C > T and 1298A > C correlate with MTHFR promoter methylation levels. PATIENTS AND METHODS: The study included 118 participants: 59 individuals with DS, 25 of which with CHD, and 59 age and gender matched controls. Genomic DNA was extracted from peripheral blood. Methylation-sensitive high-resolution melting and PCR - RFLP were used to assess methylation and genotyping. RESULTS: DS individuals showed significantly higher MTHFR methylation levels than controls (p T polymorphism. This study looked at the MTHFR gene in individuals with Down syndrome (DS), including those with and without congenital heart defects (CHDs). In this study, we explored the methylation level (a type of chemical change that can affect the way genes work) of the MTHFR gene promoter as a risk factor for the development of CHDs in individuals with DS. We also investigated whether common variations, single nucleotide polymorphisms in the MTHFR gene, were associated with these methylation level.The results showed that individuals with DS had significantly higher methylation levels of the MTHFR gene than individuals without DS. However, there was no clear difference between DS individuals with and without CHDs. Age also played a role in methylation levels. One particular gene variation, MTHFR 677C>T (rs1801133), was associated with differences in methylation, suggesting that folate metabolism might affect how this gene is regulated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methylenetetrahydrofolate Reductase (NADPH2)Down SyndromeDNA MethylationPromoter Regions, GeneticHumansFemaleMaleAdultCase-Control StudiesChildChild, PreschoolPolymorphism, Single NucleotideAdolescentHeart Defects, CongenitalYoung Adult

Stichwörter der Autor:innen

DNA methylationDown syndromecongenital heart defectsmethylenetetrahydrofolate reductasesingle nucleotide polymorphisms

Substanzen

Methylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, human

Autor:innen und Institutionen

  • Faculty of Medicine, Juraj Dobrila University of Pula, Pula, Croatia.
  • Department of Translational Research and of New Surgical and Medical Technologies, University of Pisa, Pisa, Italy.
  • Department of Gynaecology and Obstetrics, Clinical Hospital Center Rijeka, Rijeka, Croatia.
  • Faculty of Medicine, Department of Medical Biology and Genetics, University of Rijeka, Rijeka, Croatia.

ORCID-Profile: Dijana Majstorović, Andrea Stoccoro, Anita Barišić, Alena Buretić Tomljanović, Vanessa Nicolì, Fabio Coppedè, Jadranka Vraneković

Förderung

  • University of Rijeka, Rijeka, Croatia under Grant
  • Juraj Dobrila University of Pula, Croatia

Zitieren

APA

Majstorović, D., Stoccoro, A., Barišić, A., Buretić Tomljanović, A., Giangreco, M., Nicolì, V., Coppedè, F., & Vraneković, J. (2025). Increased methylation levels of the MTHFR gene promoter in Down syndrome. Epigenomics. https://doi.org/10.1080/17501911.2025.2563501

Vancouver

Majstorović D, Stoccoro A, Barišić A, Buretić Tomljanović A, Giangreco M, Nicolì V, et al. Increased methylation levels of the MTHFR gene promoter in Down syndrome. Epigenomics. 2025. doi:10.1080/17501911.2025.2563501

BibTeX
@article{Majstorovi2025,
  author = {Majstorović, Dijana and Stoccoro, Andrea and Barišić, Anita and Buretić Tomljanović, Alena and Giangreco, Marianna and Nicolì, Vanessa and Coppedè, Fabio and Vraneković, Jadranka},
  title = {Increased methylation levels of the MTHFR gene promoter in Down syndrome},
  journal = {Epigenomics},
  year = {2025},
  doi = {10.1080/17501911.2025.2563501}
}
Kostenlos starten →